Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06402643
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-15
Brief Title:
Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium
Sponsor:
Instituto de Oftalmología Fundación Conde de Valenciana
Organization:
Instituto de Oftalmología Fundación Conde de Valenciana
Study Overview
Official Title:
Comparative Analysis of Recurrence Rate Between Mini-Slet Simple Limbal Epithelial Transplantation Versus Limbal-Conjunctival Autograft Techniques in Primary Pterygium Excision
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The surgical treatment options for pterygium an abnormal growth on the eyes frontal surface can be treated with several surgical techniques The rates of pterygium coming back varies depending on the surgical technique employed and other factors related to the patient and surgery The objective of this study is to assess the efficacy and safety of incorporating a single amniotic membrane with stem cells in the treatment of primary pterygium aiming to enhance surgical outcomes and minimize recurrence rates
Detailed Description:
The surgical treatment options for pterygium an abnormal growth on the eyes surface encompass various approaches These include standard surgical excision which involves removing the pterygium using traditional surgical methods and more recently Simple Limbal Epithelial Transplantation Recurrence rate of pterygium varies depending on the surgical technique employed and other factors related to the patient and surgeryThe objective of this study is to assess the efficacy and safety of incorporating a single amniotic membrane with stem cells in the treatment of primary pterygium aiming to enhance surgical outcomes and minimize recurrence rates
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None